Steroids Increase CGRP Levels in Migraine Nerve Tissue — But Don't Cause Pain

Dexamethasone increased CGRP and its receptor expression in trigeminal ganglia, but this upregulation did not trigger head pain in rodents.

Pistolesi, Alessandra et al.·Cephalalgia : an international journal of headache·2025·lowAnimal StudyAnimal Study
RPEP-13064Animal Studylow2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
low
Sample
N=Not reported
Participants
Cell cultures and rodents treated with corticosteroids

What This Study Found

Corticosteroids upregulated CGRP and receptor expression in the trigeminal system but did not induce head pain, challenging simple CGRP-pain assumptions.

Key Numbers

Dexamethasone increased CGRP and RAMP1/CLR expression in rat CA77 cells, SHSY-5Y cells, and human PBMCs. Betamethasone 320 mcg/kg for 10 days in rats and mice. No cephalic allodynia despite increased CGRP.

How They Did This

In vitro (cell cultures: CA77, SHSY-5Y, human PBMCs) and in vivo (rat) study examining dexamethasone effects on CGRP/RAMP1/CLR expression.

Why This Research Matters

This paradoxical finding — more CGRP without more pain — deepens our understanding of what actually triggers migraine and how steroids help.

The Bigger Picture

Challenges the oversimplified view that CGRP elevation equals migraine, suggesting additional factors are needed to translate CGRP signaling into pain.

What This Study Doesn't Tell Us

Rodent model — pain assessment in animals has inherent limitations. Acute steroid exposure may differ from chronic clinical use.

Questions This Raises

  • ?If steroids increase CGRP, what other mechanism explains their headache benefit?
  • ?What cofactors are needed alongside CGRP elevation to trigger migraine?

Trust & Context

Key Stat:
No allodynia Despite increased CGRP and receptor expression, corticosteroids did not trigger head pain in rodents
Evidence Grade:
Combined in vitro and in vivo preclinical study — robust methodology for mechanistic questions, limited clinical translatability.
Study Age:
Published in 2025, contributing new insights to the CGRP-migraine mechanism debate.
Original Title:
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia.
Published In:
Cephalalgia : an international journal of headache, 45(11), 3331024251367043 (2025)
Database ID:
RPEP-13064

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Do steroids affect CGRP levels?

Yes — this study shows dexamethasone increases CGRP and its receptor expression in migraine-relevant nerve tissue.

If CGRP causes migraine, why didn't increased CGRP cause pain?

This finding suggests CGRP elevation alone isn't sufficient for migraine — other factors likely need to be present to trigger pain.

Read More on RethinkPeptides

Cite This Study

RPEP-13064·https://rethinkpeptides.com/research/RPEP-13064

APA

Pistolesi, Alessandra; Tuniz, Simone; Lapucci, Andrea; Molli, Alice; De Cesaris, Francesco; Landini, Lorenzo; Nassini, Romina; Buonvicino, Daniela; Chiarugi, Alberto. (2025). Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia.. Cephalalgia : an international journal of headache, 45(11), 3331024251367043. https://doi.org/10.1177/03331024251367043

MLA

Pistolesi, Alessandra, et al. "Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia.." Cephalalgia : an international journal of headache, 2025. https://doi.org/10.1177/03331024251367043

RethinkPeptides

RethinkPeptides Research Database. "Corticosteroid-dependent increased expression of CGRP and it..." RPEP-13064. Retrieved from https://rethinkpeptides.com/research/pistolesi-2025-corticosteroiddependent-increased-expression-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.